Matches in SemOpenAlex for { <https://semopenalex.org/work/W2732519150> ?p ?o ?g. }
- W2732519150 endingPage "293" @default.
- W2732519150 startingPage "287" @default.
- W2732519150 abstract "Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease that up to now has been associated with a poor prognosis. However, the results of the INPULSIS and ASCEND trials and the approval of nintedanib and pirfenidone have marked the beginning of a new era for IPF patients. Questions remain, however. Should these drugs be used earlier? What effect will they have on more severe disease? Will their effects last beyond the trial period? This manuscript is the outcome of a multidisciplinary meeting between pulmonology, radiology, and pathology clinicians on the use of antifibrotic agents in IPF. In our opinion, the existing data show that pirfenidone and nintedanib slow functional decline in early stages of disease. These drugs also appear to result in therapeutic benefits when administered to patients with advanced disease at diagnosis and maintain effective over time. The data also suggest that continuing antifibrotic therapy after disease progression may confer benefits, but more evidence is needed. Early diagnosis and treatment are crucial for reducing functional decline, slowing disease progression, and improving quality of life." @default.
- W2732519150 created "2017-07-14" @default.
- W2732519150 creator A5006305376 @default.
- W2732519150 creator A5007365878 @default.
- W2732519150 creator A5008840504 @default.
- W2732519150 creator A5020208383 @default.
- W2732519150 creator A5021196819 @default.
- W2732519150 creator A5021430946 @default.
- W2732519150 creator A5031664568 @default.
- W2732519150 creator A5039123084 @default.
- W2732519150 creator A5043153028 @default.
- W2732519150 creator A5051094409 @default.
- W2732519150 creator A5052663157 @default.
- W2732519150 creator A5059517740 @default.
- W2732519150 creator A5061271998 @default.
- W2732519150 creator A5065737701 @default.
- W2732519150 creator A5067740056 @default.
- W2732519150 creator A5084397046 @default.
- W2732519150 date "2017-09-01" @default.
- W2732519150 modified "2023-10-17" @default.
- W2732519150 title "Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence" @default.
- W2732519150 cites W1495091063 @default.
- W2732519150 cites W1569431722 @default.
- W2732519150 cites W1757222072 @default.
- W2732519150 cites W1801975325 @default.
- W2732519150 cites W1920916096 @default.
- W2732519150 cites W1938547050 @default.
- W2732519150 cites W1957975414 @default.
- W2732519150 cites W1993559550 @default.
- W2732519150 cites W1997731452 @default.
- W2732519150 cites W2004407498 @default.
- W2732519150 cites W2013280721 @default.
- W2732519150 cites W2018809578 @default.
- W2732519150 cites W2031752322 @default.
- W2732519150 cites W2042006898 @default.
- W2732519150 cites W2045756883 @default.
- W2732519150 cites W2057292199 @default.
- W2732519150 cites W2057863932 @default.
- W2732519150 cites W2058234974 @default.
- W2732519150 cites W2060112842 @default.
- W2732519150 cites W2098305693 @default.
- W2732519150 cites W2104372974 @default.
- W2732519150 cites W2120791222 @default.
- W2732519150 cites W2125322938 @default.
- W2732519150 cites W2131029325 @default.
- W2732519150 cites W2138871107 @default.
- W2732519150 cites W2142941142 @default.
- W2732519150 cites W2146127863 @default.
- W2732519150 cites W2146732755 @default.
- W2732519150 cites W2148343893 @default.
- W2732519150 cites W2152974152 @default.
- W2732519150 cites W2163563134 @default.
- W2732519150 cites W2167383172 @default.
- W2732519150 cites W2168666423 @default.
- W2732519150 cites W2272059546 @default.
- W2732519150 cites W2295461102 @default.
- W2732519150 cites W2302754197 @default.
- W2732519150 cites W2411490192 @default.
- W2732519150 cites W2462000645 @default.
- W2732519150 cites W2485988367 @default.
- W2732519150 cites W2507379588 @default.
- W2732519150 cites W2510319197 @default.
- W2732519150 cites W2532949559 @default.
- W2732519150 cites W2626588662 @default.
- W2732519150 cites W4296612182 @default.
- W2732519150 doi "https://doi.org/10.1016/j.rppnen.2017.05.005" @default.
- W2732519150 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28668400" @default.
- W2732519150 hasPublicationYear "2017" @default.
- W2732519150 type Work @default.
- W2732519150 sameAs 2732519150 @default.
- W2732519150 citedByCount "9" @default.
- W2732519150 countsByYear W27325191502017 @default.
- W2732519150 countsByYear W27325191502018 @default.
- W2732519150 countsByYear W27325191502019 @default.
- W2732519150 countsByYear W27325191502021 @default.
- W2732519150 countsByYear W27325191502022 @default.
- W2732519150 crossrefType "journal-article" @default.
- W2732519150 hasAuthorship W2732519150A5006305376 @default.
- W2732519150 hasAuthorship W2732519150A5007365878 @default.
- W2732519150 hasAuthorship W2732519150A5008840504 @default.
- W2732519150 hasAuthorship W2732519150A5020208383 @default.
- W2732519150 hasAuthorship W2732519150A5021196819 @default.
- W2732519150 hasAuthorship W2732519150A5021430946 @default.
- W2732519150 hasAuthorship W2732519150A5031664568 @default.
- W2732519150 hasAuthorship W2732519150A5039123084 @default.
- W2732519150 hasAuthorship W2732519150A5043153028 @default.
- W2732519150 hasAuthorship W2732519150A5051094409 @default.
- W2732519150 hasAuthorship W2732519150A5052663157 @default.
- W2732519150 hasAuthorship W2732519150A5059517740 @default.
- W2732519150 hasAuthorship W2732519150A5061271998 @default.
- W2732519150 hasAuthorship W2732519150A5065737701 @default.
- W2732519150 hasAuthorship W2732519150A5067740056 @default.
- W2732519150 hasAuthorship W2732519150A5084397046 @default.
- W2732519150 hasBestOaLocation W27325191501 @default.
- W2732519150 hasConcept C126322002 @default.
- W2732519150 hasConcept C177713679 @default.
- W2732519150 hasConcept C2777714996 @default.
- W2732519150 hasConcept C2778341716 @default.